Bottle Label 300 mg (71610 0253 60)
Allopurinol Tablet
Product Images NDC 71610-253
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 71610-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Structure (Allopurinol 01)
Figure (Allopurinol 02)
Allopurinol is a medication that is converted into oxipurinol. Both compounds have similar chemical structures that resemble dibydro-4Hpyrazolo pyrimidine and pyrazalo. Allopurinol and oxipurinol are used to treat conditions such as gout and kidney stones as they inhibit the production of uric acid which is formed from hypoxanthine and xanthine. Their chemical structure resembles the purine compounds urin-6(1H)-one, 3,7-dihydro-1Hpurine- and 7,9-dihydro-1Hpurine- and 2,5-dione 2,6,8(3H)-trione.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
